Company record
DFI Co., Ltd.
1 FDA warning letter since 2023 and 7 recalls in the last 12 months.
Get an email the day FDA posts anything new about DFI Co., Ltd..
Warning letters
-
DevicesDFI Co., Ltd.
CGMP/QSR/Medical Devices/Adulterated
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| May 13 | Class II | DFI Co., Ltd. Device |
One Step K in vitro diagnostic test REF: 81A4 The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
Uric Acid in vitro diagnostic test REF: 31H0P The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407 The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step P in vitro diagnostic test REF: 8194 The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step pH in vitro diagnostic test REF: 31I4P The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step 10A in vitro diagnostic test The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step UTI in vitro diagnostic test REF: 3374 The devices were distributed without required FDA premarket clearance or approval. |